Financial News Network (FNN) Interview with Sienna CEO Matthew Hoskin


Sienna Cancer Diagnostics IPO

Sienna Cancer Diagnostics have come up with a breakthrough method for detecting early stage bladder cancer

They are an established diagnostics company ready to expand globally

  1. Already on target to turn a profit
  2. Regulatory approval in the USA, EUR & AUS
  3. 100% rebatable in the USA






* Required

Webcast Recording - 6th of July

Join us for a live interactive webcast with the Company CEO to ask questions directly, hear what this opportunity can offer investors and their plans for the future. 

Click Here to reserve your spot, or view the most recent recording below.